These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23074315)

  • 1. Influenza B lineage circulation and hospitalization rates in a subtropical city, Hong Kong, 2000-2010.
    Chan PK; Chan MC; Cheung JL; Lee N; Leung TF; Yeung AC; Wong MC; Ngai KL; Nelson EA; Hui DS
    Clin Infect Dis; 2013 Mar; 56(5):677-84. PubMed ID: 23074315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.
    Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M
    J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-based vaccine effectiveness against influenza B lineages, Hong Kong, 2009-14.
    Chiu SS; Feng S; Chan KH; Lo JY; Chan EL; So LY; Cowling BJ; Peiris JS
    Vaccine; 2016 Apr; 34(19):2164-9. PubMed ID: 27013437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan.
    Li WC; Shih SR; Huang YC; Chen GW; Chang SC; Hsiao MJ; Tsao KC; Lin TY
    J Clin Virol; 2008 May; 42(1):45-51. PubMed ID: 18325832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community.
    Matsuzaki Y; Sugawara K; Takashita E; Muraki Y; Hongo S; Katsushima N; Mizuta K; Nishimura H
    J Med Virol; 2004 Sep; 74(1):132-40. PubMed ID: 15258979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996-2012: Implications for vaccine composition strategy.
    Paiva TM; Benega MA; Silva DB; Santos KC; Cruz AS; Hortenci MF; Barbieri MT; Monteiro MM; Barbosa HA; Carvalhanas TR
    J Med Virol; 2013 Nov; 85(11):1983-9. PubMed ID: 23926069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection.
    Sočan M; Prosenc K; Učakar V; Berginc N
    J Clin Virol; 2014 Sep; 61(1):156-60. PubMed ID: 25034374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong.
    Chiu SS; Chan KH; Chen H; Young BW; Lim W; Wong WH; Lau YL; Peiris JS
    Clin Infect Dis; 2009 Oct; 49(7):1016-21. PubMed ID: 19722912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increasing appearance of reassortant influenza B virus in Taiwan from 2002 to 2005.
    Tsai HP; Wang HC; Kiang D; Huang SW; Kuo PH; Liu CC; Su IJ; Wang JR
    J Clin Microbiol; 2006 Aug; 44(8):2705-13. PubMed ID: 16891481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine effectiveness in hospitalised Hong Kong children: Feasibility of estimates from routine surveillance data.
    Yeung KHT; Chan KCC; Chan PKS; Lam DSY; Sham PCO; Yau YS; Chan WH; Chiu WK; Ng KL; Ng DKK; Chan IMC; Nelson EAS
    Vaccine; 2018 Jun; 36(24):3477-3485. PubMed ID: 29739719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulation of influenza B lineages in northern Viet Nam, 2007-2014.
    Le TT; Pham TH; Pham TH; Nguyen le KH; Nguyen CT; Hoang VM; Tran TH; Nguyen VS; Ngo HG; Le QM
    Western Pac Surveill Response J; 2015; 6(4):17-23. PubMed ID: 26798557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-Based Pediatric Hospitalization Burden of Lineage-Specific Influenza B in Hong Kong, 2004-2014.
    Cowling BJ; Wu P; Lo JYC; Chan KH; Chan ELY; Fang VJ; So LY; Peiris JSM; Chiu SS
    Clin Infect Dis; 2017 Jul; 65(2):300-307. PubMed ID: 28387792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants.
    Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M
    J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-circulation of the two influenza B lineages during 13 consecutive influenza surveillance seasons in Italy, 2004-2017.
    Puzelli S; Di Martino A; Facchini M; Fabiani C; Calzoletti L; Di Mario G; Palmieri A; Affanni P; Camilloni B; Chironna M; D'Agaro P; Giannecchini S; Pariani E; Serra C; Rizzo C; Bella A; Donatelli I; Castrucci MR;
    BMC Infect Dis; 2019 Nov; 19(1):990. PubMed ID: 31752738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part 4. Interaction between air pollution and respiratory viruses: time-series study of daily mortality and hospital admissions in Hong Kong.
    Wong CM; Thach TQ; Chau PY; Chan EK; Chung RY; Ou CQ; Yang L; Peiris JS; Thomas GN; Lam TH; Wong TW; Hedley AJ;
    Res Rep Health Eff Inst; 2010 Nov; (154):283-362. PubMed ID: 21446214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.
    Heikkinen T; Ikonen N; Ziegler T
    Clin Infect Dis; 2014 Dec; 59(11):1519-24. PubMed ID: 25139969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective public health impact of a quadrivalent influenza vaccine in the United States.
    Crépey P; de Boer PT; Postma MJ; Pitman R
    Influenza Other Respir Viruses; 2015 Aug; 9 Suppl 1(Suppl 1):39-46. PubMed ID: 26256294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong - A decision analysis.
    You JH; Ming WK; Chan PK
    Hum Vaccin Immunother; 2015; 11(3):564-71. PubMed ID: 25714506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.